CAS RN: 1783-84-2
all cis-8,11,14-Eicosatrienoic Acid
Product Availability
Choose a grade to view its available package options.
12 package records12 with current stock4 grade groups
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
|---|---|---|---|---|---|
| Batchno.20260508 | 100mg | In stock | Shanghai | Inquiry | |
| Batchno.20250722 | 10mg | In stock | Shanghai | Inquiry | |
| Batchno.20250907 | 1mg | In stock | Shanghai | Inquiry | |
| Batchno.20250112 | 250mg | In stock | Shanghai | Inquiry | |
| Batchno.20260106 | 25mg | In stock | Shanghai | Inquiry | |
| Batchno.20250728 | 50mg | In stock | Shanghai | Inquiry | |
| Batchno.20250423 | 5mg | In stock | Shanghai | Inquiry |
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
|---|---|---|---|---|---|
| Batchno.20260316 | 5mg / 25mg / 100mg | Confirm by inquiry | Shanghai, Hebei | Inquiry |
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
|---|---|---|---|---|---|
| Batchno.20250125 | 5mg / 25mg / 100mg | Confirm by inquiry | Shanghai | 8-10 business days | Inquiry |
- Product code: ICTE0640
- Purity/Analytical Methods: >98.0%(GC)
1783-84-2 / (8Z,11Z,14Z)-icosa-8,11,14-trienoic acid
Basic Information
CAS
1783-84-2
Multi CAS
No
Molecular Formula
C20H34O2
Molecular Weight
306.500000
Exact Mass
306.255880
SMILES
CCCCC/C=C\C/C=C\C/C=C\CCCCCCC(=O)O
InChI
InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-
InChIKey
HOBAELRKJCKHQD-QNEBEIHSSA-N
Physical Properties
Physical Description
Liquid
State
Liquid
Computed Properties
Structural Parameters
Heavy atom count
22
Fraction Csp3
0.65
Rotatable bonds
15
H-bond acceptors
1
H-bond donors
1
Molar refractivity
96.13
TPSA
37.3
LogP / Solubility
WLOGP
6.44
MLOGP
5.68
XLogP3
7.2
Consensus LogP
6.44
Log S (ESOL)
-4.81
Class (ESOL)
Slightly soluble
Log S (Ali)
-6.72
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-8.8
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-0.02
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
2.5
Safety & Transport
GHS Hazard Statements
Not Classified
Reported as not meeting GHS hazard criteria by 1 of 1 companies. For more detailed information, please visit ECHA C&L website.
